Overview

Efficacy Study of Montelukast in Atopic Dermatitis Induced by Food Allergens

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
AD is a disease found in children; the focus of the study is the mechanisms associated in children with AD induced by food allergies. This study will be a randomized, double-blind, placebo-controlled, parallel group trial conducted in participants diagnosed with atopic dermatitis and food allergies. The study duration for participants will be approximately 9 weeks. A total of 20 participants will be recruited for the entire study. Each arm will consist of 10 participants.The study will enroll 20 children, male or female, 1 - 8 years of age with atopic dermatitis (AD) associated with food allergens, previously documented by skin or RAST test, before enrollment. Atopic dermatitis and gastrointestinal (GI) symptoms will be scored and followed throughout the study.
Phase:
Phase 4
Details
Lead Sponsor:
1st Allergy & Clinical Research Center
Treatments:
Montelukast